Edition:
India

Diploma PLC (DPLM.L)

DPLM.L on London Stock Exchange

1,313.00GBp
14 Aug 2018
Change (% chg)

-4.00 (-0.30%)
Prev Close
1,317.00
Open
1,316.00
Day's High
1,328.00
Day's Low
1,313.00
Volume
59,374
Avg. Vol
106,684
52-wk High
1,388.00
52-wk Low
1,003.20

Latest Key Developments (Source: Significant Developments)

Diploma Says H1 Revenue Rose 8 Percent To 234.9 Million Stg
Monday, 14 May 2018 

May 14 (Reuters) - Diploma PLC ::H1 REVENUE ROSE 8 PERCENT TO 234.9 MILLION STG.INTERIM DIVIDEND UP 10 PERCENT TO 7.7 PENCEPER SHARE.HY ADJUSTED PROFIT BEFORE TAX £40.4 MILLION VERSUS £37.1 MILLION.HY PROFIT BEFORE TAX £35.4 MILLION VERSUS £32.9 MILLION.HY ADJUSTED EARNINGS PER SHARE 26.7 PENCE.IN LIFE SCIENCES, HY REVENUES INCREASED BY 9%.IN SEALS, HY REVENUES INCREASED BY 9%.IN CONTROLS, HY REVENUES INCREASED BY 3% AGAINST A VERY STRONG COMPARATIVE LAST YEAR.  Full Article

Diploma says Richard Ingram joins board as CEO designate
Monday, 23 Apr 2018 

April 23 (Reuters) - Diploma PLC ::RICHARD INGRAM HAS TODAY JOINED BOARD AS CHIEF EXECUTIVE OFFICER ("CEO") DESIGNATE OF DIPLOMA PLC..  Full Article

Diploma posts FY pretax profit 66.8 mln stg
Monday, 20 Nov 2017 

Nov 20 (Reuters) - DIPLOMA PLC ::FY REVENUE ROSE 18 PERCENT TO 451.9 MILLION STG.FINAL DIVIDEND UP 16 PERCENT TO 16 PENCEPER SHARE.TOTAL DIVIDEND UP 15 PERCENT TO 23 PENCEPER SHARE.FY PRETAX PROFIT 66.8 MILLION STG VERSUS 54 MILLION STG YEAR AGO.TO ENHANCE GROWTH IN YEAR AHEAD BY UNLOCKING VALUE ENHANCING ACQUISITION OPPORTUNITIES​.‍STRONG FREE CASH FLOW OF £55.7M; CASH FUNDS OF £22.3M AT END OF SEPTEMBER​.‍IN LIFE SCIENCES, UNDERLYING REVENUES INCREASED BY 4%​.‍IN SEALS, FY UNDERLYING REVENUES INCREASED BY 4% REFLECTING AN IMPROVING TREND IN INDUSTRIAL ACTIVITY IN NORTH AMERICA​.‍IN CONTROLS,FY UNDERLYING REVENUES INCREASED BY 14%, DRIVEN BY NEW PROJECT ACTIVITY, RECOVERY IN SOME END USER MARKETS.‍ACQUISITION EXPENDITURE OF £20.1M THIS YEAR​.  Full Article

Diploma sees full-year results in line with expectations
Wednesday, 31 Aug 2016 

Diploma Plc : Group has delivered a robust performance in second half of year and is on track to report results for full year in line with expectations . Reported revenues for year ending 30 september 2016 are expected to increase by ca. 14 pct . Translational currency effects are expected to add ca. 4 pct to group revenues, driven by substantial decline in UK sterling since Brexit decision in june 2016 . On an underlying basis, after adjusting for impact of acquisitions and currency effects, group revenues for year are expected to increase by ca. 2 pct . In life sciences, underlying revenue growth for full year is expected to be ca. 3 pct . Operating margins have remained robust in second half and are expected to be broadly consistent with first half and to remain ca. 100 bps below prior year . Group's free cash flow for year ending 30 September 2016 is likely to be substantially ahead of last year .Group's balance sheet is also very strong and is expected to return to a modest net cash funds position at 30 September 2016.  Full Article